4//SEC Filing
Balthaser Kevin 4
Accession 0001957554-26-000003
CIK 0001557746other
Filed
Jan 4, 7:00 PM ET
Accepted
Jan 5, 4:27 PM ET
Size
19.6 KB
Accession
0001957554-26-000003
Insider Transaction Report
Form 4
Balthaser Kevin
Chief Financial Officer
Transactions
- Exercise/Conversion
Common Stock
2025-12-31+73,750→ 166,358 total - Tax Payment
Common Stock
2025-12-31$3.01/sh−19,934$60,001→ 146,424 total - Exercise/Conversion
Common Stock
2026-01-01+7,500→ 153,924 total - Tax Payment
Common Stock
2026-01-01$3.01/sh−2,250$6,772→ 151,674 total - Exercise/Conversion
Common Stock
2026-01-02+13,200→ 164,874 total - Tax Payment
Common Stock
2026-01-02$2.88/sh−4,461$12,848→ 160,413 total - Exercise/Conversion
Restricted Stock Units
2025-12-31−73,750→ 0 total→ Common Stock (73,750 underlying) - Exercise/Conversion
Restricted Stock Units
2026-01-01−7,500→ 7,500 total→ Common Stock (7,500 underlying) - Exercise/Conversion
Restricted Stock Units
2026-01-02−13,200→ 13,600 total→ Common Stock (13,200 underlying)
Footnotes (5)
- [F1]Each restricted stock unit represents a contingent right to receive one share of common stock of the issuer.
- [F2]The transaction reported represents the withholding of shares by the issuer to satisfy the Reporting Person's tax withholding obligations in connection with the vesting and settlement of restricted stock units described in this Form 4.
- [F3]50% of the shares underlying these restricted stock units vested on each of December 31, 2024 and December 31, 2025.
- [F4]The shares underlying these restricted stock units vest in four equal installments on the first, second, third and fourth anniversaries of January 1, 2023, subject to the Continuous Service of the Reporting Person (as defined in the Plan) as of each such date.
- [F5]The shares underlying these restricted stock units vest as to 33% on January 2, 2025, 33% on January 2, 2026, and 34% on January 2, 2027, subject to the Continuous Service (as defined in the Plan) of the Reporting Person as of each such date.
Documents
Issuer
Aclaris Therapeutics, Inc.
CIK 0001557746
Entity typeother
Related Parties
1- filerCIK 0001957554
Filing Metadata
- Form type
- 4
- Filed
- Jan 4, 7:00 PM ET
- Accepted
- Jan 5, 4:27 PM ET
- Size
- 19.6 KB